We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bristol-Myers Off The Hook In Plavix Probe

Law360 (February 27, 2007, 12:00 AM EST) -- Bristol-Myers Squibb Co. said a federal investigation found no violations of securities laws stemming from the company's actions in negotiating a patent settlement over blockbuster drug Plavix last year.

The drug maker said in a filing with the U.S. Securities and Exchange Commission on Monday that the Office of the U.S. Attorney for the District of New Jersey had found no securities law violations and did not intend to take further action regarding Bristol-Myers’s deferred-prosecution agreement, set to expire in June.

However, the company hasn’t been...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.